Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Singaporean (SGX) Pharma Industry Analysis

UpdatedMay 09, 2025
DataAggregated Company Financials
Companies4
  • 7D-11.8%
  • 3M-1.8%
  • 1Y17.3%
  • YTD1.6%

In the last week, the Pharma industry is flat overall, with Haw Par standing out by going down 8.3%. The past year has been better, since the industry has gained 33% in that time. Earnings are forecast to grow by 5.8% annually.

Industry Valuation and Performance

Has the Singaporean Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 09 May 2025S$2.6bS$459.4mS$230.2m11x11.5x5.7x
Sun, 06 Apr 2025S$3.0bS$459.8mS$230.3m12.4x12.8x6.4x
Tue, 04 Mar 2025S$2.9bS$459.8mS$230.3m12.1x12.8x6.4x
Thu, 30 Jan 2025S$2.7bS$449.4mS$232.7m9.6x11.4x5.9x
Sat, 28 Dec 2024S$2.6bS$449.4mS$232.7m9.5x11.1x5.7x
Mon, 25 Nov 2024S$2.6bS$449.4mS$232.7m9.6x11.2x5.8x
Wed, 23 Oct 2024S$2.5bS$448.3mS$232.7m9.5x11x5.7x
Fri, 20 Sep 2024S$2.5bS$448.2mS$232.7m9.4x10.9x5.6x
Sun, 18 Aug 2024S$2.4bS$438.1mS$233.4m9.3x10.2x5.4x
Tue, 16 Jul 2024S$2.4bS$431.9mS$216.0m9.6x11.2x5.6x
Thu, 13 Jun 2024S$2.3bS$432.0mS$216.0m9.5x10.5x5.3x
Sat, 11 May 2024S$2.3bS$417.3mS$214.6m9.7x10.5x5.4x
Mon, 08 Apr 2024S$2.3bS$417.2mS$214.6m10x10.7x5.5x
Wed, 06 Mar 2024S$2.3bS$417.2mS$214.6m9.9x10.6x5.4x
Fri, 02 Feb 2024S$2.2bS$371.1mS$172.1m12.4x12.9x6x
Sun, 31 Dec 2023S$2.3bS$371.0mS$172.1m12.7x13.3x6.2x
Tue, 28 Nov 2023S$5.4bS$1.6bS$310.6m12.4x17.3x3.5x
Thu, 26 Oct 2023S$4.9bS$1.5bS$326.5m9.9x15.1x3.2x
Sat, 23 Sep 2023S$5.3bS$1.5bS$326.8m9.9x16.2x3.4x
Mon, 21 Aug 2023S$5.4bS$1.5bS$314.0m10.2x17.1x3.5x
Wed, 19 Jul 2023S$5.9bS$1.5bS$289.8m10.5x20.4x3.8x
Fri, 16 Jun 2023S$6.3bS$1.5bS$289.8m10.8x21.8x4.1x
Sun, 14 May 2023S$6.5bS$1.6bS$294.4m11.3x22x4.1x
Tue, 11 Apr 2023S$6.0bS$1.6bS$268.7m11.5x22.5x3.9x
Thu, 09 Mar 2023S$5.6bS$1.4bS$263.5m9.5x21.2x4.1x
Sat, 04 Feb 2023S$5.3bS$1.4bS$265.3m9.1x20.1x3.8x
Mon, 02 Jan 2023S$5.0bS$1.4bS$262.5m8.8x18.9x3.6x
Wed, 30 Nov 2022S$5.0bS$1.3bS$257.2m8x19.6x3.8x
Fri, 28 Oct 2022S$4.6bS$1.3bS$246.2m9.9x18.6x3.5x
Sun, 25 Sep 2022S$4.5bS$1.3bS$246.9m10.5x18.4x3.4x
Tue, 23 Aug 2022S$4.8bS$1.4bS$254.7m11.4x19x3.5x
Thu, 21 Jul 2022S$4.9bS$1.3bS$228.6m10x21.4x3.7x
Sat, 18 Jun 2022S$4.9bS$1.3bS$229.2m10.4x21.5x3.7x
Mon, 16 May 2022S$4.7bS$1.3bS$226.8m10.8x20.7x3.6x
Price to Earnings Ratio

20.7x


Total Market Cap: S$4.7bTotal Earnings: S$226.8mTotal Revenue: S$1.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Singaporean Pharma Industry Price to Earnings3Y Average 15.8x202320242025
Current Industry PE
  • Investors are pessimistic on the Singaporean Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 13.0x which is lower than its 3-year average PE of 15.9x.
  • The 3-year average PS ratio of 4.7x is lower than the industry's current PS ratio of 6.5x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have declined 30% per year.
  • This means that the cost of doing business could be reducing since sales have declined but profits have remained steady.

Industry Trends

Which industries have driven the changes within the Singaporean Healthcare industry?

SG Market0.26%
Healthcare-3.92%
Pharma-11.76%
Pharma-11.76%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
42C iX BiopharmaS$0.0215.0%
+S$888.0k		-47.5%PS2.7x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

1J5

S$0.28

Hyphens Pharma International

7D

-3.5%

1Y

3.8%

H02

S$11.38

Haw Par

7D

-12.2%

1Y

18.2%

42C

S$0.021

iX Biopharma

7D

5.0%

1Y

-47.5%